Pedro G.
- Country
- Portugal
- Department
- Neurology
Research Overview
- A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy (X-TOLE4)
- A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
Data & Insights
Has run more than one trial at 41 of 75 partner sites.
Specializations
Epilepsy Management
This investigator specializes in the treatment of epileptic disorders, with particular emphasis on different seizure types and their clinical management.
- Focal-Onset Seizures
- Primary Generalized Tonic-Clonic Seizures
The research focus encompasses therapeutic approaches for patients with various seizure manifestations.
Neurological Therapeutics
The investigator's work centers on evaluating novel therapeutic interventions for neurological conditions, particularly in the context of seizure control and management.
- Long-term Therapeutic Safety
- Seizure Frequency Reduction
Their research activities include assessment of therapeutic efficacy in reducing seizure occurrence and evaluating long-term treatment outcomes.
Clinical Assessment
Expertise in conducting clinical evaluations of anticonvulsant therapies, focusing on both safety and efficacy parameters.
- Treatment Tolerability Studies
- Therapeutic Response Assessment
The investigator's work involves comprehensive evaluation of treatment responses in epilepsy patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.